Q: Is it safe to drink alcohol while using this medication
However, most patients who tolerate the treatment well would suffice with a monthly follow-up
What Patients Consider With Low-Dose Tirzepatide Key trade-offs: Microdosing tirzepatide (weekly doses below the FDA-approved 2.5 mg starting dose) has no randomized-trial evidence, is subject to the same FDA boxed warnings and contraindications as standard dosing, and requires a licensed-provider evaluation
Simultaneously, GLP-1 treatment upregulates the expression of ABCA1, thereby repairing the cholesterol efflux from islet -cells that have sustained damage by lipotoxicity, reducing the cellular cholesterol content, improving cellular lipid deposition, and restoring islet -cell function, which is consistent with the results of previous studies (Murao et al., 2009
[1] [3] The sensation of feeling cold whilst on GLP-1 therapy is likely related to several interconnected physiological mechanisms, primarily associated with weight loss rather than a direct medication effect